Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jhin Jieh Lim

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical and Translational Medicine|May 7, 2019
Epigenetics of hepatocellular carcinomaTan Boon Toh, Jhin Jieh Lim, Edward Kai-Hua Chow
Molecular Cancer|February 3, 2017
Epigenetics in cancer stem cellsTan Boon Toh, Jhin Jieh Lim, Edward Kai-Hua Chow
Stem Cell Investigation|November 2, 2022
Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinomaJhin Jieh Lim, Edward Kai-Hua Chow, Tan Boon Toh
Hepatic Oncology|April 11, 2020
JAK/STAT signaling in hepatocellular carcinomaJustin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
ACS Applied Materials & Interfaces|November 14, 2019
Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma TherapyMengjie Gu, Tan Boon Toh, Lissa Hooi, et al.
Journal of Hepatology|September 22, 2019
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinomaTan Boon Toh, Jhin Jieh Lim, Lissa Hooi, et al.
Nanoscale|September 20, 2021
Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D modelsJingru Xu, Mengjie Gu, Lissa Hooi, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 15, 2022
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitorsJhin Jieh Lim, Lissa Hooi, Yock Young Dan, et al.
Experimental Hematology & Oncology|June 2, 2020
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaXi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, et al.
Bioengineering & Translational Medicine|February 3, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentAgata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical and Translational Medicine|May 7, 2019
Epigenetics of hepatocellular carcinomaTan Boon Toh, Jhin Jieh Lim, Edward Kai-Hua Chow
Molecular Cancer|February 3, 2017
Epigenetics in cancer stem cellsTan Boon Toh, Jhin Jieh Lim, Edward Kai-Hua Chow
Stem Cell Investigation|November 2, 2022
Eph receptor B2 (EPHB2) regulates cancer stem cell-like properties in hepatocellular carcinomaJhin Jieh Lim, Edward Kai-Hua Chow, Tan Boon Toh
Hepatic Oncology|April 11, 2020
JAK/STAT signaling in hepatocellular carcinomaJustin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
ACS Applied Materials & Interfaces|November 14, 2019
Nanodiamond-Mediated Delivery of a G9a Inhibitor for Hepatocellular Carcinoma TherapyMengjie Gu, Tan Boon Toh, Lissa Hooi, et al.
Journal of Hepatology|September 22, 2019
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinomaTan Boon Toh, Jhin Jieh Lim, Lissa Hooi, et al.
Nanoscale|September 20, 2021
Enhanced penetrative siRNA delivery by a nanodiamond drug delivery platform against hepatocellular carcinoma 3D modelsJingru Xu, Mengjie Gu, Lissa Hooi, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 15, 2022
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitorsJhin Jieh Lim, Lissa Hooi, Yock Young Dan, et al.
Experimental Hematology & Oncology|June 2, 2020
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myelomaXi Yun Zhang, Deepa Rajagopalan, Tae-Hoon Chung, et al.
Bioengineering & Translational Medicine|February 3, 2021
IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug developmentAgata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, et al.
Pageof 2